SALMON at Medway, a senior living community, is collaborating with Mount Sinai’s Icahn School of Medicine in New York City to conduct a study aimed at improving various aspects of life for residents with Alzheimer’s disease and other types of dementia.
The study will seek to improve the sleep quality, mood, depression, agitation, and stress levels of the residents by providing tailored lighting in a longitudinal, controlled study.
“We already know that bright lighting during the day supports a good sleep-wake pattern; our goal from this study is to determine the best lighting enhanced pattern for residents with Alzheimer’s disease and other types of dementia,” Diane Tonelli, director of tapestry at SALMON, said in a press release.
The study will provide residents with a 24-hour circadian lighting plan with the expectation for this to improve their overall well-being. The results will be measured against a number of different scales including sleep quality and agitation scales.
